Introduction
The aorta is the first and largest arterial segment directly connected to the heart and is an expandable reservoir for multiple vital functions. Physiologically, it is a high-risk section for the development of stenosis (1) . The function of the aorta is associated with the wall structure; the intima, media, and adventitia (2) . The intima is originated from the endothelium, a thin layer of endothelial cells, sub-endothelial connective tissue and internal elastic lamina. Media contains a protein network of elastin-enriched collagen, fibroblasts, and vascular smooth muscle cells. (3) Adventitia, the outer protecting layer of the media, includes connective tissue and fibroblasts. The endothelium creates a semi-infiltrative barrier between the blood and surrounding tissues and, controls the permeability of cells (4) . Endothelial cells (ECs) are related by tight junctions and would lead to the vascular homeostasis, thrombosis, fibrinolysis, vascular tone, tumorigenesis, and blood-borne cell adhesion. Furthermore, the endothelial cells relate to the para-cellular pathways and leukocyte rolling process, are involved in metabolic activities and can be activated by a number of circulating agents such as amines, nucleotides, lipoproteins, and reactive oxygen species (5) . In addition, inflammatory conditions and the activation of endothelial cells by chemokines lead to the expression of adhesion proteins.
As a result, endothelial cells have been applied as a primary cellular source to study the physiological and pathophysiological processes of various vascular diseases (6) . The endothelial cell sources are isolated from the human arteries and vein umbilical cords. Several methods were designed and developed for the separation of endothelial cells from human arteries (7) . In this study, we modified the isolation method of the intimal endothelial cells from the human thoracic aorta. In addition, we stud- 
Methods

Study design and Setting
Endothelial cells were isolated from the human normal aortic segments. The cellular isolation was evaluated using histology, CD31 marker and adhesion processes.
Tissue Sample and Ethical Approval
Normal aortic samples were prepared from subjects with brain death from transplant Organ Procurement Unit (OPU) center of Masih Daneshvari Hospital. The samples were placed in saline/amphotericin B/gentamicin/ PenStrep (0.25 μg / ml, 50 mg/ml and %6, respectively) (8) and were transferred into the laboratory of Biochemistry department (IUMS) in safe conditions. The University Ethics Committee approved the study (93-03-30-25069). 2. Perform the sterile filtration process (filter, 0.2 µm) then, store the collagenase solution at 4 °C.
Preparation of Endothelium Cell Medium
1. Prepare Endothelial Cell Growth Medium MV for freshly consumption (Cat. No.: C-22022-500ml; PromoCell) (7) containing endothelial cell growth complement, ECGS / H 0.004 ml / ml, hEGF-5 50 μg / 500 μl, HC-500 500 μg / 500 μl, supplemented with 5% fetal calf serum (FCS-25 0.05 ml / ml), 1% antibiotics (10000 U Penicillin/ml, 10000 U Streptomycin/ml ,gibco, Lot: 1697549) and amphotericin B (0.25 μg / ml).
2. Store the tissue samples at 4 °C.
Isolation of Intimal Endothelial Cells
1. Transfer the tissue sample (length, 8-15 cm) into a petri dish. Remove all adherent sections on the outside surface of the aorta using surgical scissors. Wash the inner and outer surfaces of the aorta with saline and PBS buffer (Fig. 1a) .
2. Fill aorta with PBS buffer containing collagenase D and clamp two sides of the aorta using forceps (Fig. 1b) .
3. Transfer the PBS /collagenase D buffer-containing samples slowly into the incubator (37 ° C, 5% CO2) for 20-30 minutes.
4. Rinse the inner section of the aorta with serum-free EGM-MV (PromoCell) and collect the released endothelial cells (ECs) in a petri dish (Fig. 2) .
5. Repeat the isolation process (steps 2-4), several times.
Human Aortic Endothelial Cell Culture
1. Prepare the cell pellet from the released cells using centrifugation technique (2500 rpm, 7 minutes).
2. Resuspend and seed the cell pellet in serum-free EGM-MV.
3. Culture the isolated cells in the serum-EGM-MV medium in 12-well plates after separation of detached pieces.
4. Incubate the cells in endothelial cell culture in an incubator (37 °C, 5% CO2) and change daily the culture medium for one week (Fig. 3) . 5. Detach the endothelial cells (ECs) by adding trypsin (37 °C, 5% CO2, 5 minutes) after 7 days and transfer the cells to 15 ml falcon containing 10 ml of endothelial cell culture medium (EGM-MV) and Fetal Calf Serum (10%) to stop trypsin function.
6. Centrifuge (2500-3000 rpm, 6 minutes) and resediment with cold PBS (containing 10% FBS).
7. Measure the expression of endothelial CD31 marker to confirm endothelial cells. For this purpose, wash the cells twice with cold PBS (5 min) and count the CD31+ cells using the AB applied biosystems Attune (Fig. 4) .
Histology
1. Fix the pieces of intact and collagenase/PBS bufferexposed aortic tissues in PFA (10%, 96 hours) according to the routine paraffin-embedding technique.
2. Prepare the tissue cross-sections perpendicular to the axis of blood flow (Fig. 5) .
3. Stain routinely the thick paraffin sections (5-10 micrometers) by hematoxylin-eosin and evaluate the sections with invert microscope (Nikon Eclipse TE 2000-E inverted microscope, 10x) before and after acting collagenase D. 2. Add endothelial cells (50,000-100,000) to gelatincoated 48-well plate.
Isolated ECs and Leucocyte Adhesion
3. Culture cells onto the coated substrate, where the adherent cells prepare a cellular monolayer after 48-72 hours.
4. Treat the endothelial monolayer with LPS (Cat. No.: L6529-1MG; Sigma Aldrich, Korea) (1 μg /ml, 6 hours) (10) on the seventh day of EC culture.
5. Isolate the human monocytes using RosetteSep kit (Stem cell Technologies), an immunodensity technique for the isolation of monocytes from fresh whole blood (11).
5.1. Incubate the falcon containing whole blood sample (5 ml) and RosetteSep™ Enrichment Cocktail for 20 minutes.
5.2. Add an equal volume of FBS (%2)/PBS to the blood sample and mix gently.
5.3. Centrifuge (2500 rpm, 20 minutes). 5.4. Wash enriched cells with FBS (%2)/PBS after removing the medium layer.
5.5. Make a monocyte suspension (0.5 -1.0 x 106/ml) in serum-free media and add LeukoTracker for preparation of final concentration of 1X.
6. Incubate (37ºC, 60 minutes), centrifuge (1000 rpm, 2 minutes), aspirate the medium, wash pellet and resuspend it in a serum-free media.
7. Wash pellet with the serum-free media after elimination of supernatant. Then, transfer the monocyte solution containing LeukoTracker (200 µL) to the endothelial monolayer-containing wells and incubate for 30-90 minutes.
8. Carefully aspirate the media from each well and wash each well (3 times) with Wash buffer (250 µL) to remove the unbound cells.
9. Aspirate the final wash solution and add Lysis buffer (150 µL) to each well. Incubate at room temperature with shaking for 5 minutes.
10. Transfer 100 µL of the final mixture to each well of the 96-well plate for fluorescence analysis (SpectraMax Gemini XS Fluorometer, 485/538 nm filter) (Fig. 6 ).
Discussion
Atherosclerosis is associated with molecular and cellular events in arteries (12, 13) . In the present study, a method is described for the isolation of endothelial cells from the human aorta and their functions in the adhesion process. Most methods used for primary EC isolation are involved with the enzyme digestion by a collagenase solution to detach the ECs from the basement membrane of large vessels (14) . However, costly techniques are applied often for small vessels following an appropriate culture medium (15) . Oosterhoff et al. suggested a combined en- 4 dothelial cell isolation technique, containing the inversion of the small vessels and floating them in enzyme solution that may lead to cellular contamination (16) . These techniques require validation on considering the heterogeneity of EC intravascular population (17) and the possibility of changing the expression of cell surface markers in the pathologic states (18, 19) . The technique suggested for the isolation of aortic primary endothelial cells in this paper may be used for human macrovascular tissues. The technique is based on the collagenase digestion restriction of vessel's exterior surface. The procedure is able to isolate endothelial cells with higher purity and at least contamination. Other antibody-based techniques, however, might improve the cellular purity but they are time-consuming and expensive. There are some quality control techniques to guarantee the method reliability such as the transendothelial resistance that may be identified by the measurement of anti-CD31 or anti-von Willebrand factor (vWF). In this study, the anti-CD31 level was measured in the isolated endothelial cells. There are some recommendations on the method troubleshooting;
i. The need to a sterile working area. ii. The use of a fresh tissue samples.
iii. The evaluation of enzyme quality. iv. The use of amphotericin B.
Conclusions/Significance
The technique might be used for the isolation of endothelial cells from aortic segments. The isolated endothelial cells are able to prepare the proper primary cultures and provide a reliable source for investigating the processes of atherosclerosis and vessel restenosis.
